Amy L. Gawad

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma”.

Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma

medRxiv(2021)10.1101/2021.12.10.21267485

N/A

1.4DataRank · unranked

38 citations

Kelly A. Gebo, Shmuel Shoham, Evan M. Bloch, Bryan Lau, Aarthi Shenoy +53 more

Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection

medRxiv(2021)10.1101/2021.12.13.21267611

N/A

0.507DataRank · unranked

10 citations

Evan M. Bloch, Arturo Casadevall, Daniel F. Hanley, Bryan Lau, Kelly A. Gebo +50 more

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

JCI Insight(2024)10.1172/jci.insight.178460

N/A

0.427DataRank · unranked

12 citations

Anna Yin, Caelan Barranta, John S. Lee, Christopher Caputo, Jaiprasath Sachithanandham +76 more

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

medRxiv(2023)10.1101/2023.04.13.23288353

N/A

0.104DataRank · unranked

1 citations

Anna Yin, Caelan Barranta, John S. Lee, Christopher Caputo, Jaiprasath Sachithanandham +76 more

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials

Transfusion(2023)10.1111/trf.17485

N/A

0DataRank · unranked

11 citations

Jay S. Raval, James H. Paxton, Giselle Mosnaim, Bela Patel, Shweta Anjan +53 more

COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial

Microbiology Spectrum(2023)10.1128/spectrum.03286-23

N/A

0DataRank · unranked

11 citations

Xianming Zhu, Andrew D. Redd, Kelly A. Gebo, Alison G. Abraham, Eshan U. Patel +42 more

Early Treatment, Inflammation and Post-COVID Conditions

medRxiv(2023)10.1101/2023.02.13.23285855

N/A

0DataRank · unranked

5 citations

Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza Baksh, Alison G. Abraham +38 more

Selecting trial centers using a standardized, automated site assessment survey instrument (SASI)

Contemporary Clinical Trials(2024)10.1016/j.cct.2024.107583

N/A

0DataRank · unranked

4 citations

Shannon Hillery, Ryan Majkowski, Bradley J. Barney, Daniel Amirault, Sarah J. Nelson +14 more

Clinical trial coordination of multifaceted ethical and regulatory oversight entities during the COVID-19 public health emergency

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108207

N/A

0DataRank · unranked

0 citations

Jessica Mendoza, Megan Singleton, Ryan Majkowski, Erica Hopkins, Jordyn Carll +11 more

How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?

Transfusion(2022)10.1111/trf.16871

N/A

0DataRank · unranked

20 citations

Aaron A.R. Tobian, Shmuel Shoham, Daniel F. Hanley, Thomas J. Gniadek, Edward R. Cachay +32 more

Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

The Lancet Microbe(2023)10.1016/s2666-5247(23)00171-4

N/A

0DataRank · unranked

77 citations

Kelly A. Gebo, Alison G. Abraham, Feben Habtehyimer, Eshan U. Patel, Oliver Laeyendecker +43 more

Early antibody treatment, inflammation, and risk of post-COVID conditions

mBio(2023)10.1128/mbio.00618-23

N/A

0DataRank · unranked

22 citations

Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza Baksh, Allison G. Abraham +38 more